General
Showing 433–448 of 2270 results
-
Article: Co-inhibition of BRAF and MEK signalling delays progression in BRAF-mutant metastatic melanoma
€3.03 Add to cart -
Article: Combating acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer
€3.03 Add to cart -
Article: Combined PD-1 and CTLA4 inhibition delays progression in advanced melanoma
€3.03 Add to cart -
Article: Comment on a previously published practice guidelines article
€3.03 Add to cart -
Article: Comparison of HIL interferences on three hemostasis analyzers and contribution of a preanalytical module for routine coagulation assays
€3.03 Add to cart -
Article: Comparison of point-of-care instruments I-STAT, ACTPlus and Hemochron Signature Plus for measurement of activated clotting time (ACT)
€3.03 Add to cart -
Article: Complete response of Sweet syndrome associated with myelodysplastic syndrome to 5-azacytidine
€3.03 Add to cart -
Article: Concerning a previously published Introduction
€3.03 Add to cart -
Article: Concerning a previously published practice guidelines article
€3.03 Add to cart -
Article: Concomitant JAK2 V617F positive essential thrombocytemia and BCR-ABL1 positive chronic myeloid leukaemia masked by imatinib therapy for a gastrointestinal stromal tumour
€3.03 Add to cart -
Article: Concurrent chronic myeloid leukaemia and myelodysplastic/myeloproliferative neoplasm with SF3B1 mutation and fulminant thrombocytosis
€3.03 Add to cart -
Article: Confirmed benefit of blinatumomab in difficult to treat patients with acute lymphoblastic leukemia
€3.03 Add to cart -
Article: Confirmed clinical benefit of BRAF and MEK co-inhibition in BRAF-mutant metastatic melanoma: updated data from coBRIM and BRIM7
€3.03 Add to cart -
Article: Confirmed survival benefit of combined BRAF and MEK inhibition in advanced BRAF mutant melanoma
€3.03 Add to cart -
Article: Congratulations! Winner of the first CSL Behring Encouragement Grant
€3.03 Add to cart -
Article: Congress Calendar
€3.03 Add to cart
